These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 8622873

  • 41. Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12.
    Englefield P, Foulkes WD, Campbell IG.
    Br J Cancer; 1994 Nov; 70(5):905-7. PubMed ID: 7947096
    [Abstract] [Full Text] [Related]

  • 42. Genetic and epigenetic alterations of the candidate tumor-suppressor gene MYO18B, on chromosome arm 22q, in colorectal cancer.
    Nakano T, Tani M, Nishioka M, Kohno T, Otsuka A, Ohwada S, Yokota J.
    Genes Chromosomes Cancer; 2005 Jun; 43(2):162-71. PubMed ID: 15751041
    [Abstract] [Full Text] [Related]

  • 43. Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas.
    Hoang-Xuan K, Merel P, Vega F, Hugot JP, Cornu P, Delattre JY, Poisson M, Thomas G, Delattre O.
    Int J Cancer; 1995 Feb 08; 60(4):478-81. PubMed ID: 7829260
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type 2 gene.
    Watkins D, Ruttledge MH, Sarrazin J, Rangaratnam S, Poisson M, Delattre JY, Rouleau GA.
    Cancer Genet Cytogenet; 1996 Nov 08; 92(1):73-8. PubMed ID: 8956876
    [Abstract] [Full Text] [Related]

  • 46. Frequent loss of heterozygosity at telomeric loci on 22q in sporadic colorectal cancers.
    Yana I, Kurahashi H, Nakamori S, Kameyama M, Nakamura T, Takami M, Mori T, Takai S, Nishisho I.
    Int J Cancer; 1995 Jan 17; 60(2):174-7. PubMed ID: 7829211
    [Abstract] [Full Text] [Related]

  • 47. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines.
    Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R.
    Jpn J Cancer Res; 1996 Nov 17; 87(11):1153-9. PubMed ID: 9045944
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Molecular analysis of genes involved in colorectal tumors. Markers of tumor predisposition and progression].
    Grandjouan S, Henry I, Haliassos A.
    Gastroenterol Clin Biol; 1991 Nov 17; 15(1):34-48. PubMed ID: 2010067
    [No Abstract] [Full Text] [Related]

  • 50. Genetic variations of the midkine (MK) gene in human sporadic colorectal and gastric cancers.
    Ahmed KM, Shitara Y, Kuwano H, Takenoshita S, Uchimuro K, Shinozawa T.
    Int J Mol Med; 2000 Sep 17; 6(3):281-7. PubMed ID: 10934290
    [Abstract] [Full Text] [Related]

  • 51. Evidence for a common molecular pathogenesis in colorectal, gastric, and pancreatic cancer.
    Neuman WL, Wasylyshyn ML, Jacoby R, Erroi F, Angriman I, Montag A, Brasitus T, Michelassi F, Westbrook CA.
    Genes Chromosomes Cancer; 1991 Nov 17; 3(6):468-73. PubMed ID: 1663781
    [Abstract] [Full Text] [Related]

  • 52. Absence of secretory phospholipase A2 gene alterations in human colorectal cancer.
    Riggins GJ, Markowitz S, Wilson JK, Vogelstein B, Kinzler KW.
    Cancer Res; 1995 Nov 15; 55(22):5184-6. PubMed ID: 7585570
    [Abstract] [Full Text] [Related]

  • 53. Loss of ARID1A expression is uncommon in gastric, colorectal, and prostate cancers.
    Kim MS, Je EM, Yoo NJ, Lee SH.
    APMIS; 2012 Dec 15; 120(12):1020-2. PubMed ID: 23030592
    [No Abstract] [Full Text] [Related]

  • 54. Deletion mapping reveals two regions of chromosome 8 allele loss in colorectal carcinomas.
    Yaremko ML, Wasylyshyn ML, Paulus KL, Michelassi F, Westbrook CA.
    Genes Chromosomes Cancer; 1994 May 15; 10(1):1-6. PubMed ID: 7519868
    [Abstract] [Full Text] [Related]

  • 55. Clonal allele loss in gastrointestinal cancers.
    Fey MF, Hesketh C, Wainscoat JS, Gendler S, Thein SL.
    Br J Cancer; 1989 May 15; 59(5):750-4. PubMed ID: 2736209
    [Abstract] [Full Text] [Related]

  • 56. Expressional and mutational analysis of ATRX gene in gastric, colorectal and prostate cancers.
    Je EM, An CH, Yoo NJ, Lee SH.
    APMIS; 2012 Jun 15; 120(6):519-20. PubMed ID: 22583365
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Evaluation of PARVG located on 22q13 as a candidate tumor suppressor gene for colorectal and breast cancer.
    Castellví-Bel S, Castells A, Johnstone CN, Piñol V, Pellisé M, Elizalde JI, Romo N, Rustgi AK, Piqué JM.
    Cancer Genet Cytogenet; 2003 Jul 01; 144(1):80-2. PubMed ID: 12810262
    [Abstract] [Full Text] [Related]

  • 59. Frequent somatic allelic inactivation of the E-cadherin gene in gastric carcinomas.
    Becker KF, Höfler H.
    J Natl Cancer Inst; 1995 Jul 19; 87(14):1082-4. PubMed ID: 7616601
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.